university | Science and Enterprise

A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from e… https://t.co/CvnMEFT0Cm
about 7 hours ago
New post on Science and Enterprise: Start-Up Developing Engineered B-Cell Therapies https://t.co/vMgdwnIXdi #Science #Business
about 7 hours ago
Global drug maker Roche Group is acquiring an experimental antiviral therapy for Covid-19 infections taken as a ora… https://t.co/e2d7m6HG1E
about 11 hours ago
New post on Science and Enterprise: Roche Gains Covid-19 Oral Drug Candidate https://t.co/nh27g6uCwi #Science #Business
about 11 hours ago
The day that America lost $100 billion because of an immigration visa ban https://t.co/OfEx6SFwxA via @BrookingsInst
about 24 hours ago

Carb-X Funding Nanoscale Sponge to Treat Sepsis

By Alan, on October 21st, 2020%

A company developing tiny particles made of cellular material to soak-up toxins in the body received a $4 million award to advance its sepsis treatment. . . . → Read More: Carb-X Funding Nanoscale Sponge to Treat Sepsis

Software Designed to Model, Visualize Brain Circuits

By Alan, on October 20th, 2020%

An academic-industry team designed a web-based software tool to ease the computer modeling, simulation, and visualization of the brain’s nerve cell circuits. . . . → Read More: Software Designed to Model, Visualize Brain Circuits

Covid-19 Vaccine Challenge Trial Underway

By Alan, on October 20th, 2020%

Researchers in the U.K. are beginning a human challenge trial that intentionally exposes volunteers to SARS-CoV-2 viruses to test candidate vaccines. . . . → Read More: Covid-19 Vaccine Challenge Trial Underway

Lilly Gains Neuro Disease Biotech in $1.36B Deal

By Alan, on October 15th, 2020%

Drug maker Eli Lilly and Co. is acquiring Disarm Therapeutics, a biotechnology company developing treatments for neurodegenerative disorders. . . . → Read More: Lilly Gains Neuro Disease Biotech in $1.36B Deal

Cancer Center, Biotech Partner on Off-the-Shelf T-Cells

By Alan, on October 15th, 2020%

MD Anderson Cancer Center and Allogene Therapeutics Inc. agreed to jointly study the company’s cancer treatments derived from donated T-cells. . . . → Read More: Cancer Center, Biotech Partner on Off-the-Shelf T-Cells

Blood Test Shown to Predict Covid-19 Symptom Severity

By Alan, on October 14th, 2020%

A blood test that measures the ratio of two key immune system proteins is shown in tests with patients to predict the severity of Covid-19 symptoms. . . . → Read More: Blood Test Shown to Predict Covid-19 Symptom Severity

Gene Therapy Delivery Tech Licensed in $1.8B Deal

By Alan, on October 14th, 2020%

A biotechnology company creating synthetic viruses with artificial intelligence to deliver gene therapies is licensing its technology to drug maker Roche. . . . → Read More: Gene Therapy Delivery Tech Licensed in $1.8B Deal

Individual Cells Explored with Virtual Reality

By Alan, on October 13th, 2020%

A new software package uses virtual reality to allow biologists and medical researchers to visualize and explore inside individual cells in three dimensions. . . . → Read More: Individual Cells Explored with Virtual Reality

Start-Up Gains Access to Vaccine Nasal Spray Technology

By Alan, on October 12th, 2020%

A company developing techniques to deliver vaccines like Covid-19 with a nasal spray received an opportunity to license the process from University of Houston. . . . → Read More: Start-Up Gains Access to Vaccine Nasal Spray Technology

New Funds Advance Hand-Wrist Neural Rehab Device

By Alan, on October 12th, 2020%

Developers of a system to help people with spinal cord injuries regain use of their hands and wrists, are configuring the device for home use. . . . → Read More: New Funds Advance Hand-Wrist Neural Rehab Device

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise